Boston, MA, United States of America

Lucia Sobrin

This inventor holds 1 USPTO granted patent. Top assignee: Massachusetts Eye and Ear Infirmary. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lucia Sobrin. Retrieved from https://idiyas.com/inventor/lucia-sobrin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lucia Sobrin: Innovator in Ocular Treatment

Introduction

Lucia Sobrin is a prominent inventor based in Boston, MA, known for her significant contributions to the field of ocular health. She has developed innovative methods aimed at treating ocular inflammatory disorders, which can have a profound impact on patients' vision.

Latest Patents

Lucia Sobrin holds a patent for "Methods for treating ocular inflammatory disorders." This patent outlines methods for treating conditions such as macular edema using an AMP kinase activator, specifically 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR). The methods described in her patent focus on reducing inflammation, thereby minimizing the loss of vision or visual function associated with these ocular disorders.

Career Highlights

Lucia Sobrin is affiliated with the Massachusetts Eye and Ear Infirmary, where she continues to advance her research and clinical applications. Her work is pivotal in enhancing treatment options for patients suffering from ocular inflammatory conditions.

Collaborations

Some of her notable coworkers include Demetrios Vavvas and Joan W. Miller, who contribute to the collaborative efforts in research and development within the field of ocular health.

Conclusion

Lucia Sobrin's innovative work in treating ocular inflammatory disorders exemplifies the impact of research and invention in improving patient care. Her contributions are vital in the ongoing quest to enhance vision health and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…